Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MOB1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
REEP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDE3B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CAP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM72A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
HMMR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM189-UBE2V1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BRI3BP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF144A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LARS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101927746 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
USP31 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC440934 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100506748 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRKDC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TTC3P1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FERMT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SSR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHML - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SERBP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on